The Global Atherectomy Devices Market Is Witnessing High Growth Owing To the High Incidence of Cardiac Issues in the World

 

Atherectomy Devices

Global Atherectomy Devices Market by Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices), by Application (Cardiovascular, Neurovascular, and Peripheral Vascular), by End User (Hospitals, Ambulatory Surgical Centers, and Medical Institutes) and by Geography - Trends and Forecast to 2025.

Market Overview:

Atherectomy is a medical procedure that aims to improve blood flow in a person's arteries. A blockage in the artery can cause pain, fatigue, and other problems. This type of surgery can be performed in an outpatient setting, although some patients may have to stay in the hospital for a few days after the procedure. Depending on the size and number of arteries affected, the procedure may take as little as two hours. The atherectomy procedure is typically combined with balloon angioplasty, which is used to open up the artery. However, an atherectomy is an option for people who have not had angioplasty. In addition, it can be used to clear calcified plaques in veins. If the atherectomy does not remove the plaque completely, a stent may be placed to help the artery remain open.

Competitive Landscape:

Major players operating in the global Atherectomy Devices Market include Biotronik, Straub Medical AG, Minnetronix, Inc., Cardinal Health, Inc., C. R. Bard, Inc, Avinger, Inc, Boston Scientific Corporation, Cardiovascular Systems, Inc., Koninklijke Philips N.V., and Medtronic plc.

Key Market Drivers:

The increasing incidence of heart surgeries in the world is expected to augment the growth of the global Atherectomy Devices Market. For instance, according to DayToDay Health, more than 500,000 open heart surgeries take place every year in the world. An X-ray is usually taken to determine the extent of the blockage. Contrast dye is then injected into the artery. This helps the doctor to see the blockage and locate the area. Before the atherectomy, the doctor will perform a catheter-based angiography. The catheter is then threaded through the artery, moving towards the heart. During the procedure, the patient will lie flat to prevent bleeding. A sedative will be administered, making the patient sleepy. After the procedure is over, the patient will be moved to a recovery room. It can take several hours before the patient is able to move around. Most patients are able to return home the same day. Moreover, high research and developments related to heart surgeries are estimated to enhance the growth of the global Atherectomy Devices Market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several restraints in the global atherectomy devices market. Several essential treatments and cardiovascular procedures were postponed. For instance, in March 2022, Annals of Thoracic Surgery's research study analyzed around 717,103 adult cardiac surgery patients and over 20 million COVID-19 patients informed that there has been a 2.7% reduction in adult cardiac surgery along with around 65.5% reduction in elective cases.

Key Takeaways:

·       North America is expected to dominate the growth of the global Atherectomy Devices Market, owing to the high prevalence of major market players in the region. For instance, in August 2022, AngioDynamics, Inc. stated that the Auryon Atherectomy System has received the 510(k) clearance for their expanded indication, which also includes arterial thrombectomy.

·       The Asia Pacific is estimated to witness high growth in the global Atherectomy Devices Market, owing to the increasing incidence of cardiovascular issues in the region. For instance, according to the Australian Government Department of Health and Aged Care, more than 1.2 million Australians suffer from 1 or more cardiac conditions.